SANIGEN Decides 900 Million Won Third-Party Allotment to Largest Shareholder GC Partners... Dilution and Control Strengthening Impact
SANIGEN filed a correction on June 22, 2026 regarding a third-party allotment of 637,845 new shares to its largest shareholder, GC Partners.
The issue price is 1,411 won, a 10% discount to the reference price of 1,567 won, and the proceeds of approximately 900 million won will be used for operating expenses.
The dilution rate is about 4.8%, which is moderate, but the largest shareholder's stake will increase, strengthening control.
All allotted shares are subject to a one-year lock-up, limiting short-term selling pressure, but the counterparty's lack of audited financials raises transparency concerns.
[AI Summary]SANIGEN's rights offering is aimed at securing operating funds and increasing the largest shareholder's stake; while dilution is limited to 4.8%, the 10% discount and uncertain use of proceeds may weigh on the stock price in the short term.
KOSDAQ Filing Information
[Correction of Description] Report on Major Events (Decision on Paid-in Capital Increase)